Tiba joins Norwest as a biotech investor with 20+ years of research and investment experience. She invests in healthcare with a focus on early- to mid-stage companies within the therapeutics sector.

Prior to joining Norwest, Tiba spent over 10 years at Novo Holdings A/S, one of the top life sciences investment firms, with offices in the United States and Europe. In her previous role, she was responsible for the deployment of ~$280 million of capital in private biotech, MedTech, and HCIT companies. Earlier in her career, Tiba worked as a banker focused on M&A, licensing, and financing transactions involving biotech/pharma.

Tiba attended the University of California Irvine where she received a bachelor of science degree in physics with a biomedical concentration. She also holds a Ph.D. in biophysics from the University of California San Francisco, where she also did her postdoctoral fellowship. Tiba is also a published author of scientific articles and book chapters covering rational drug design.